Free Trial
NASDAQ:HSIC

Henry Schein (HSIC) Stock Price, News & Analysis

$72.31
+1.27 (+1.79%)
(As of 07/26/2024 ET)
Today's Range
$71.19
$72.44
50-Day Range
$64.09
$74.60
52-Week Range
$60.01
$82.63
Volume
1.08 million shs
Average Volume
1.11 million shs
Market Capitalization
$9.26 billion
P/E Ratio
24.43
Dividend Yield
N/A
Price Target
$81.67

Henry Schein MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.54 Rating Score
Upside/​Downside
12.9% Upside
$81.67 Price Target
Short Interest
Healthy
3.76% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.42
Upright™ Environmental Score
News Sentiment
0.96mentions of Henry Schein in the last 14 days
Based on 17 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.72%
From $5.16 to $5.61 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.75 out of 5 stars

Medical Sector

54th out of 936 stocks

Medical & Hospital Equipment Industry

1st out of 3 stocks

HSIC stock logo

About Henry Schein Stock (NASDAQ:HSIC)

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

HSIC Stock Price History

HSIC Stock News Headlines

Baird Upgrades Henry Schein (HSIC)
Henry Schein (NASDAQ:HSIC) Upgraded to "Strong-Buy" at Baird R W
Brace Yourself: Experts calling for Bitcoin to hit $100k
For the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.
Henry Schein (NASDAQ:HSIC) Upgraded to Outperform by Robert W. Baird
Labcorp Holdings Inc (N6B.SG)
Analyst Expectations For Henry Schein's Future
Brace Yourself: Experts calling for Bitcoin to hit $100k
For the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.
See More Headlines
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/07/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Current Symbol
NASDAQ:HSIC
CUSIP
80640710
Employees
25,000
Year Founded
1932

Price Target and Rating

Average Stock Price Target
$81.67
High Stock Price Target
$96.00
Low Stock Price Target
$65.00
Potential Upside/Downside
+12.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.54
Research Coverage
13 Analysts

Profitability

Net Income
$416 million
Pretax Margin
4.06%

Debt

Sales & Book Value

Annual Sales
$12.34 billion
Cash Flow
$6.88 per share
Book Value
$33.01 per share

Miscellaneous

Free Float
126,591,000
Market Cap
$9.26 billion
Optionable
Optionable
Beta
0.87

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

HSIC Stock Analysis - Frequently Asked Questions

How have HSIC shares performed this year?

Henry Schein's stock was trading at $75.71 at the beginning of 2024. Since then, HSIC stock has decreased by 4.5% and is now trading at $72.31.
View the best growth stocks for 2024 here
.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) issued its earnings results on Tuesday, May, 7th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.01 by $0.09. The firm's quarterly revenue was up 3.7% on a year-over-year basis.
Read the conference call transcript
.

When did Henry Schein's stock split?

Henry Schein shares split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were payable to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein's board initiated a stock buyback program on Thursday, August 18th 2022, which permits the company to repurchase $400,000,000 in shares, according to EventVestor. This means that the company could buy up to 4% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board believes its stock is undervalued.

What is Stanley M. Bergman's approval rating as Henry Schein's CEO?

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Does Henry Schein have any subsidiaries?

Henry Schein subsidiaries include these companies: Prism Medical Products LLC, Elite Computer Italia, Southern Anesthesia & Surgical, Marrodent, Dental Cremer, RxWorks, Dental Trey, and others.

Who are Henry Schein's major shareholders?

Henry Schein's top institutional shareholders include Swedbank AB (2.05%), Bank of New York Mellon Corp (0.73%), Sumitomo Mitsui Trust Holdings Inc. (0.24%) and Raymond James & Associates (0.23%). Insiders that own company stock include James P Breslawski, Stanley M Bergman, Gerald A Benjamin, Michael S Ettinger, Lorelei Mcglynn, Bradford C Connett, Mark E Mlotek, David B Brous Jr, Walter Siegel, Philip A Laskawy, Kurt P Kuehn and Scott Philip Serota.
View institutional ownership trends
.

How do I buy shares of Henry Schein?

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA) and QUALCOMM (QCOM).

This page (NASDAQ:HSIC) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners